The global multiple sclerosis drugs market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Factors which are influencing the market growth are growing research in the field of MS to develop innovative therapies, increasing awareness about the disease and rising healthcare expenditures. However, high cost related with treatment of drugs, lack of availability of drugs and stringent regulatory approvals are hampering the market growth. Moreover, technological ... Read more